Abiopharma

🔍 TING HOCK MING (Executive)

Company: TRIO-TECH INTERNATIONAL (TRT)

Report Date: 2026-04-13

Detailed Transactions and Holdings:

• Sold 6,000 shares of Common Stock at $6.73 per share (Direct)
  Date: 2026-04-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 173,644.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 12,600 shares of Common Stock at $6.93 per share (Direct)
  Date: 2026-04-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 161,044.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at price ranging from $6.57 to $6.84, inclusive. The reporting person undertakes to provide Trio-Tech International Inc, any security holder of Trio-Tech International Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at price ranging from $6.90 to $6.98, inclusive. The reporting person undertakes to provide Trio-Tech International Inc, any security holder of Trio-Tech International Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.